The present invention provides the compound of Formula I of an administration, (chemical formula should be inserted into here. ) include the pharmaceutical compositions of one or more reducing agents, and thrombus, embolism, Hypercoagulability or the method for fibre modification variation are formed for treating or preventing using the compound. Compound is the selectivity factor XIa inhibitor or double inhibitor of factor XIa and plasma kallikrein.
